FBLG
FBLG
NASDAQ · Biotechnology

Fibrobiologics Inc

$1.36
-0.03 (-2.16%)
As of Sep 28, 10:38 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,388.2% upside
Low Target $14.74
Average Target $20.24
High Target $23.30
Current Price $1.36
Current
$1.36
Target
$20.24
$14.74 $20.24 avg $23.30
Scenario Analysis
Bear Case
$14.74
983.8%
Low target
Base Case
$20.24
+1,388.2%
Avg target
Bull Case
$23.30
+1,613.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$12.40
-89.0% from high
52-Week Low
$0.62
+119.4% from low
Target vs 52W High
$20.24
+63.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%